CVS Health Corporation

CVS.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVS.DE stands at 69.98B. In comparison, UNH.DE has a market cap of 224.97B. Regarding current trading prices, CVS.DE is priced at $55.32, while UNH.DE trades at $248.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVS.DE currently has a P/E ratio of 14.75, whereas UNH.DE's P/E ratio is 11.61. In terms of profitability, CVS.DE's ROE is +0.07%, compared to UNH.DE's ROE of +0.24%. Regarding short-term risk, CVS.DE is less volatile compared to UNH.DE. This indicates potentially lower risk in terms of short-term price fluctuations for CVS.DE.

CVS.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CVS.DE stands at 69.98B. In comparison, CGN.DE has a market cap of 79.64B. Regarding current trading prices, CVS.DE is priced at $55.32, while CGN.DE trades at $280.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CVS.DE currently has a P/E ratio of 14.75, whereas CGN.DE's P/E ratio is 17.29. In terms of profitability, CVS.DE's ROE is +0.07%, compared to CGN.DE's ROE of +0.08%. Regarding short-term risk, CVS.DE is more volatile compared to CGN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for CVS.DE.